vimarsana.com
  • Home
  • Live Updates
  • Praxis Precision Stock Jumps 26% On Positive Results For Phase 2 Study Of Epilepsy Treatment : comparemela.com

    • Praxis Precision Stock Jumps 26% On Positive Results For Phase 2 Study Of Epilepsy Treatment

    Shares of Praxis Precision Medicines, Inc. (PRAX) jumped over 26% on Tuesday morning after the company reported positive results from a phase 2 study of epilepsy treatment.

    Related Keywords

    Marcio Souza , Praxis Precision Medicines Inc , Nasdaq , Praxis Precision Medicines , Precision Medicines , Photo Paroxysmal Response , Praxis Precision ,

    © 2024 Vimarsana

    comparemela.com © 2020. All Rights Reserved.